Although most cases of PTCL, NOS are negative or only weakly positive for CD30 in only a minority of tumor cells (4–6), a small subset exhibit diffuse and strong CD30 expression(CD30high PTCL, NOS). Here, TNFRSF8 is linked to neoplasm.